Aquaporin A/S Launches New Rights Issue to Finance Growth and Development

Aquaporin A/S Launches New Rights Issue

In a strategic move aimed at bolstering its growth and development, Aquaporin A/S, a pioneering Danish water technology company, has announced a new rights issue. This initiative comes as part of their dedication to innovative water filtration processes leveraging biotechnology. The board of directors approved this rights issue, allowing existing shareholders to subscribe to an impressive total of 77,536,770 new shares at a nominal price of DKK 1 per share. If fully subscribed, this offering could yield up to DKK 78 million, which is crucial for the company’s ambitious plans to enhance water purification technologies.

Ulrik Lund Jakobsen, the Chief Executive Officer of Aquaporin, emphasized the company’s unique position within the water technology sector, which aligns with their vision for a sustainable future. "Aquaporin operates a focused business that prioritizes research and development while capitalizing on our innovative membrane purification technologies. Our products effectively eliminate impurities from water, a resource of substantial importance globally," he stated.

The rights issue is designed to empower the company to meet its operational needs and advance their technological developments, including their Aquaporin Inside® technology. This technology, which has garnered attention for its ecological approach to addressing water issues, is positioned for commercialization in the upcoming years.

Aquaporin plans to distribute ten pre-emptive rights to existing shareholders for every share they hold. For every three pre-emptive rights exercised, investors can subscribe for one new share at the specified price. Should current shareholders opt not to participate fully, they risk facing a dilution of their ownership by as much as 77%.

Niels Heering, the Chair of the Board, mentioned that the rights issue is a direct response to a thorough strategic review process supported by their shareholders. It aims to secure adequate funding for the foreseeable future and support efforts toward achieving profitability. He expressed optimism regarding Aquaporin's position for the next phase of growth, focusing on a refined commercial model and cost optimization strategies.

The company is not setting a minimum amount for the rights issue; however, they have received significant pre-subscription and guarantee commitments from substantial existing shareholders, which indicate strong backing for the initiative.

The details of the rights issue highlight that the trading of pre-emptive rights will take place from January 5, 2026, with subscription periods commencing on January 7, 2026, and lasting until January 20, 2026. Following the completion of this process, the newly issued shares will be listed on Nasdaq Copenhagen under a temporary ISIN code, with an expectation of merging into the existing share's ISIN shortly after.

As Aquaporin prepares for this new chapter, they remain committed to addressing global water challenges through their innovative approaches, ensuring the combination of biology, chemistry, and physics creates effective water solutions. By engaging their loyal shareholder base through this rights issue, Aquaporin is taking proactive steps towards a sustainable and profitable future in the water technology arena.

For investors looking to be part of this venture, thorough reading of the forthcoming information document provided by the company is advised, and potential participation is encouraged when the rights issue formally opens.